115 related articles for article (PubMed ID: 35610140)
1. Adherence to lipid monitoring and its impact on treat intensification of LDL-C lowering therapies at an urban academic medical center.
Tran C; Vo V; Taylor P; Koehn DA; Virani SS; Dixon DL
J Clin Lipidol; 2022; 16(4):491-497. PubMed ID: 35610140
[TBL] [Abstract][Full Text] [Related]
2. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
Jia X; Ramsey DJ; Rifai MA; Ahmed ST; Akeroyd JM; Dixon DL; Gluckman TJ; Nambi V; Ballantyne CM; Petersen LA; Stone NJ; Virani SS
Am J Cardiol; 2020 Mar; 125(6):874-879. PubMed ID: 31952841
[TBL] [Abstract][Full Text] [Related]
3. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
[TBL] [Abstract][Full Text] [Related]
4. Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures?
Deshotels MR; Virani SS; Ballantyne CM
Curr Cardiol Rep; 2021 Jul; 23(9):116. PubMed ID: 34269897
[TBL] [Abstract][Full Text] [Related]
5. Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification.
Rana JS; Virani SS; Moffet HH; Liu JY; Coghlan LA; Vasadia J; Ballantyne CM; Karter AJ
Am J Med; 2022 May; 135(5):603-606. PubMed ID: 34861203
[TBL] [Abstract][Full Text] [Related]
6. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
7. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease.
Cannon CP; Khan I; Klimchak AC; Reynolds MR; Sanchez RJ; Sasiela WJ
JAMA Cardiol; 2017 Sep; 2(9):959-966. PubMed ID: 28768335
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.
Lowenstern AM; Li S; Navar AM; Roger VL; Robinson JG; Goldberg AC; Virani SS; Lee LV; Wilson PWF; Louie MJ; Peterson ED; Wang TY
J Am Heart Assoc; 2018 Sep; 7(18):e009251. PubMed ID: 30371214
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
10. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
11. Assessment of compliance with lipid guidelines in an academic medical center.
Schwiesow SJ; Nappi JM; Ragucci KR
Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
[TBL] [Abstract][Full Text] [Related]
12. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.
Jia X; Al Rifai M; Ramsey DJ; Ahmed ST; Akeroyd JM; Nambi V; Ballantyne CM; Petersen LA; Stone NJ; Virani SS
Am J Med; 2019 Sep; 132(9):e693-e700. PubMed ID: 31103643
[TBL] [Abstract][Full Text] [Related]
13. Early impact of the 2018 AHA/ACC/multisociety cholesterol guideline on lipid monitoring after statin initiation.
Tunoa JA; Billups SJ; Lowe RN; Saseen JJ
J Clin Lipidol; 2020; 14(6):784-790. PubMed ID: 32978094
[TBL] [Abstract][Full Text] [Related]
14. Utilization and adherence to guideline-recommended lipid-lowering therapy at an academic medical center.
Alburikan KA; Asiri RM; Alhammad AM; Abuelizz AA; Bawazeer GA; Aljawadi MH
Ann Saudi Med; 2017; 37(4):276-281. PubMed ID: 28761026
[TBL] [Abstract][Full Text] [Related]
15. Correlates of repeat lipid testing in patients with coronary heart disease.
Virani SS; Woodard LD; Wang D; Chitwood SS; Landrum CR; Urech TH; Pietz K; Chen GJ; Hertz B; Murawsky J; Ballantyne CM; Petersen LA
JAMA Intern Med; 2013 Aug; 173(15):1439-44. PubMed ID: 23817669
[TBL] [Abstract][Full Text] [Related]
16. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol.
Hulten E; Bittencourt MS; Singh A; O'Leary D; Christman MP; Osmani W; Abbara S; Steigner ML; Truong QA; Nasir K; Rybicki FF; Klein J; Hainer J; Brady TJ; Hoffmann U; Ghoshhajra BB; Hachamovitch R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2014 Jul; 7(4):629-38. PubMed ID: 24906356
[TBL] [Abstract][Full Text] [Related]
18. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
[TBL] [Abstract][Full Text] [Related]
19. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
[TBL] [Abstract][Full Text] [Related]
20. Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.
Romanelli RJ; Ito MK; Karalis DG; Huang HC; Iorga ŞR; Kam IW; Thompson S; Azar KMJ
J Clin Lipidol; 2020; 14(3):305-314. PubMed ID: 32362513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
